These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25594616)

  • 1. Concise review: induced pluripotency by defined factors: prey of oxidative stress.
    Qi S; Fang Z; Wang D; Menendez P; Yao K; Ji J
    Stem Cells; 2015 May; 33(5):1371-6. PubMed ID: 25594616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic stability during cellular reprogramming: Mission impossible?
    von Joest M; Búa Aguín S; Li H
    Mutat Res; 2016 Jun; 788():12-6. PubMed ID: 26851988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.
    Hsu YC; Chen CT; Wei YH
    Biochim Biophys Acta; 2016 Apr; 1860(4):686-93. PubMed ID: 26779594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.
    Prigione A; Hossini AM; Lichtner B; Serin A; Fauler B; Megges M; Lurz R; Lehrach H; Makrantonaki E; Zouboulis CC; Adjaye J
    PLoS One; 2011; 6(11):e27352. PubMed ID: 22110631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Instability of iPSCs and Challenges in Their Clinical Applications.
    Yoshihara M; Oguchi A; Murakawa Y
    Adv Exp Med Biol; 2019; 1201():23-47. PubMed ID: 31898780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of the inactive X chromosome and post-transcriptional reprogramming of Xist in iPSCs.
    Kim JS; Choi HW; Araúzo-Bravo MJ; Schöler HR; Do JT
    J Cell Sci; 2015 Jan; 128(1):81-7. PubMed ID: 25380819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.
    Prigione A; Fauler B; Lurz R; Lehrach H; Adjaye J
    Stem Cells; 2010 Apr; 28(4):721-33. PubMed ID: 20201066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reprogramming mechanism and genetic stability of induced pluripotent stem cells (iPSCs)].
    Ren C; Sun H; Wang L; Zhang G; Fan Y; Yan G; Wang D; Wang F
    Yi Chuan; 2014 Sep; 36(9):879-87. PubMed ID: 25252305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells.
    Phanthong P; Raveh-Amit H; Li T; Kitiyanant Y; Dinnyes A
    Biogerontology; 2013 Dec; 14(6):591-602. PubMed ID: 23963527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine.
    Poetsch MS; Strano A; Guan K
    Stem Cells; 2022 Jun; 40(6):546-555. PubMed ID: 35291013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy.
    Navarro S; Moleiro V; Molina-Estevez FJ; Lozano ML; Chinchon R; Almarza E; Quintana-Bustamante O; Mostoslavsky G; Maetzig T; Galla M; Heinz N; Schiedlmeier B; Torres Y; Modlich U; Samper E; Río P; Segovia JC; Raya A; Güenechea G; Izpisua-Belmonte JC; Bueren JA
    Stem Cells; 2014 Feb; 32(2):436-46. PubMed ID: 24420904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
    Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
    Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aging signature: a hallmark of induced pluripotent stem cells?
    Rohani L; Johnson AA; Arnold A; Stolzing A
    Aging Cell; 2014 Feb; 13(1):2-7. PubMed ID: 24256351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xist repression shows time-dependent effects on the reprogramming of female somatic cells to induced pluripotent stem cells.
    Chen Q; Gao S; He W; Kou X; Zhao Y; Wang H; Gao S
    Stem Cells; 2014 Oct; 32(10):2642-56. PubMed ID: 24965076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
    Suh W
    Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and genetic modification of induced pluripotent stem cells.
    Schambach A; Cantz T; Baum C; Cathomen T
    Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells.
    Ji J; Sharma V; Qi S; Guarch ME; Zhao P; Luo Z; Fan W; Wang Y; Mbabaali F; Neculai D; Esteban MA; McPherson JD; Batada NN
    Stem Cell Reports; 2014 Jan; 2(1):44-51. PubMed ID: 24511469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.